QIAGEN N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.45 CHF | +0.84% |
|
-.--% | -.--% |
| 31/05 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
| 31/05 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CHF)
9 597 101 220
Capitalization (USD)
9 597 101 220
Net sales (USD)
1 965 311 000
Free-Float
96.86 %
Free-Float capitalization (CHF)
10 402 824 946
Free-Float capitalization (USD)
9 381 787 678
Highs and lows
5 years
34.56
41.91
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2018 | +7.89% | ||
| 2017 | +3.78% | ||
| 2016 | +14.45% | ||
| 2015 | +11.76% |
- Stock Market
- Equities
- QGEN Stock
- QGEN Stock
- Quotes Qiagen N.V.
